Created in 2004 (United States), AMI ANÄMIE MANAGEMENT own 142 sister brands and 17477 competing brands. The AMI ANÄMIE MANAGEMENT brand is owned by Amgen, a company listed in New York. The sector of AMI ANÄMIE MANAGEMENT is Drug Manufacturers.

AMI ANÄMIE MANAGEMENT is a brand of Amgen (AMGN) Share price

International deposit : 2004 Business sector Drug Manufacturers

Share price and profitability of the share Amgen (AMI ANÄMIE MANAGEMENT)

Buy Amgen share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 269.38

Portfolio valuation
Amgen (AMI ANÄMIE MANAGEMENT) over 5 years* USD 401.68

Stock market history Amgen (AMI ANÄMIE MANAGEMENT)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Amgen

Tepezza
Tepezza
Viela Bio
Viela Bio
Abgenix
Abgenix
BioVex
BioVex
Immunex
Immunex
Avidia
Avidia
See more brands of Amgen

Rival brands
AMI ANÄMIE MANAGEMENT

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS